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Recent advances in high-throughout sequencing technologies have made it possible to
accurately assign copy number (CN) at CN variable loci. However, current analytic methods
often perform poorly in regions in which complex CN variation is observed. Here we
report the development of a read depth-based approach, CNVrd2, for investigation of
CN variation using high-throughput sequencing data. This methodology was developed
using data from the 1000 Genomes Project from the CCL3L1 locus, and tested using
data from the DEFB103A locus. In both cases, samples were selected for which paralog
ratio test data were also available for comparison. The CNVrd2 method first uses
observed read-count ratios to refine segmentation results in one population. Then a
linear regression model is applied to adjust the results across multiple populations, in
combination with a Bayesian normal mixture model to cluster segmentation scores into
groups for individual CN counts. The performance of CNVrd2 was compared to that of two
other read depth-based methods (CNVnator, cn.mops) at the CCL3L1 and DEFB103A loci.
The highest concordance with the paralog ratio test method was observed for CNVrd2
(77.8/90.4% for CNVrd2, 36.7/4.8% for cn.mops and 7.2/1% for CNVnator at CCL3L1
and DEF103A). CNVrd2 is available as an R package as part of the Bioconductor project:
http://www.bioconductor.org/packages/release/bioc/html/CNVrd2.html.
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INTRODUCTION
Copy number variation (CNV) encompassing genes is a com-
mon phenomenon in the human genome, and has been shown to
be associated with variation in phenotype (Gonzalez et al., 2005;
Freeman et al., 2006; McKinney et al., 2008, 2010, 2012; Bentley
et al., 2010). Accurate CN assignment is required for studies asso-
ciating CNV loci with phenotype. However, accurately measuring
gene CN by direct molecular methods over large numbers of sam-
ples is challenging, and is often complicated by the existence of
paralogous gene pairs. As a consequence, phenotypic association
data, largely obtained by quantitative polymerase chain reaction
(Q-PCR) based methods, should be regarded with caution (He
et al., 2009; Marques et al., 2010; Carpenter et al., 2011; McKinney
and Merriman, 2012). In response to the increasing utility of
high-throughput sequencing (HTS) technologies, we previously
developed the read depth based method CNVrd (Nguyen et al.,
2013). We demonstrated its ability to accurately assign CN using
genome-wide HTS data duplications and deletions at the FCGR
locus, where CN ranges from zero to four. To date, however, the
utility of this approach for genotyping loci at which a greater
range of CN exists is untested.
One complex CN variable locus is CCL3L1. Copy number
variation at CCL3L1 has been associated with susceptibility to
HIV infection (Liu et al., 2010), autoimmune disease (Burns
et al., 2005; Mamtani et al., 2008; McKinney et al., 2008) and
asthma (Lee et al., 2011). The median CN of CCL3L1 is 2 in
European populations and >2 in other populations (Gonzalez
et al., 2005). Evaluation of the role of CCL3L1 CNV in common
disease has been hampered by robustness of methodology, par-
ticularly that based on Q-PCR (He et al., 2009; Carpenter et al.,
2011). Similarly, CNV within the beta-defensin locus on chro-
mosome 8, which includes the DEFB4 and DEFB103A genes that
vary in CN en bloc (a range of two to nine copies) (Groth et al.,
2008), has been associated with various infectious and inflam-
matory phenotypes (Bentley et al., 2010; Mehlotra et al., 2012;
Zhou et al., 2012). As is the case for CCL3L1, however, inter-
pretation of these data, and further progress in studying the role
of beta-defensin CN in medical phenotypes, is hampered by the
difficulty in accurately measuring CN in large numbers of sam-
ples (Aldhous et al., 2010). Paralog ratio test (PRT) copy number
data are available at both CCL3L1 and the beta-defensin locus
(Armour et al., 2007; Walker et al., 2009), and thus provide an
important resource for developing and validating new HTS read
depth-based copy number assignment approaches. The PRT uses
multiple probes to compare CN to an invariant paralog and is cur-
rently regarded as the gold-standard method for measuring CN at
complex loci (McKinney and Merriman, 2012).
Here we describe the development of CNVrd2 as an extension
of the CNVrd methodology, and demonstrate the application of
this new approach by assigning copy number at the development
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locus CCL3L1, and test locus DEFB103A, both of which have
previously had CN measured using the PRT.
SUBJECTS AND METHODS
HTS AND MICROARRAY DATA USED
The genomic coordinates (hg19) used in this research
were derived from the NCBI (http://www.ncbi.nlm.nih.
gov/) and were CCL3 (chr17:34415602-34417506), CCL3L1
(chr17:34623842-34625730), CCL3L3 (chr17:34623842-3462
5730), CCL4 (chr17:34431220-34433014), CCL4L1 (chr17:345
38468-34540275), DEFB103A (chr8:7738726-7740105) and
DEFB103B (chr8:7286410-7287682). Data were downloaded
from the European Bioinformatics Institute (EBI) FTP server
(ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/data/ and ftp://ftp.1000
genomes.ebi.ac.uk/vol1/ftp/phase1/data/). For CCL3L1, 2535
samples (Table 1) downloaded from 26 populations on February
10, 2014 were used. These had an average coverage of 2.8–40.6×
over a 2Mb region around the CCL3L1 locus. For DEFB103A,
2535 samples (Table 2) downloaded on August 13, 2013 were
used. These had an average coverage of 2.8–30.9× (median 6.9×)
over the 2Mb region around the DEFB103A locus. Only samples
sequenced on Illumina platforms were used, so as to avoid cross
platform variability. BWA-aligned data were available in BAM
format (Li et al., 2009).
THE WORKFLOW OF THE PIPELINE
The entire pipeline is represented in Figure 1. The pipeline is used
to measure CN for a specific gene or locus. Four main steps are
described below.
PIPELINE WORKFLOW: IDENTIFICATION OF APPROXIMATE
BOUNDARIES OF MEASURED REGIONS
Samples were segmented as previously described for the CNVrd
procedure (Nguyen et al., 2013). The results of the segmentation
process were used to obtain approximate boundaries of copy-
number variable regions encompassing the gene being measured.
CNVrd2 used different percentiles and standard deviations of
segmentation results to visually obtain information of CNVs at
loci. Then, standard deviations were used to obtain approximate
boundaries as follows (Step C, Figure 1).
To identify approximate boundaries of putative polymorphic
regions (Step C, Figure 1), the coordinates of regions having sim-
ilar segmentation results for each sample were obtained from the
segmentation process applied to the large 1-2Mb regions across
all samples. Next, all these coordinates were combined to generate
sub-regions, and segmentation results generated by the original
segmentation analysis for each sample were obtained. Finally,
the standard deviations and various percentiles of segmentation
results of each sub-region across the 2535 samples were calculated
and plotted to visually confirm CNV. Windows exhibiting large
standard deviations were used to identify approximate positions
of putative regions being assigned CN.
PIPELINE WORKFLOW: OBTAINING SEGMENTATION SCORES FOR
INDIVIDUAL SAMPLES AT THE MEASURED LOCUS
This step was similar to our previous pipeline (CNVrd) but with
some modifications (Step D, Figure 1) added to obtain more
reliable segmentation scores. If the entirety of the gene of inter-
est was placed in a single segment then the segmentation score for
the gene was the segmentation score for that region. If the gene
was split into multiple segments, each having the same sign then
the segmentation score for the gene was calculated as the length-
weighted average across the segments (NA18612 for example in
Step D, Figure 1). Otherwise, if a segment at the boundary of
the gene had a different sign from other sub-regions of the gene
(HG00254 for example) and the boundary segment’s length was
less than a specific threshold (here the threshold was set to half
the window size) then the z-score for the boundary segment was
calculated, where the z-score is defined as the value of the stan-
dardized observed read-count ratio (Nguyen et al., 2013). If the
z-score had the same sign as the segmentation scores from other
sub-regions of the gene, then the segmentation score for the gene
was again calculated as the length-weighted average across the
other segments. For all other situations the gene of interest was
assigned a segmentation score of zero, reflecting the population
average at that locus.
PIPELINE WORKFLOW: ADJUSTMENT OF THE SEGMENTATION
PROCESS FOR MULTIPLE POPULATIONS
The pipeline was applied to each of the five major populations
(European, East Asian, West African, South Asian, and Americas)
to obtain segmentation scores (SSP: the segmentation scores for
a single major population). This identified the scores in each of
the large populations, but did not allow comparisons between
the populations. Therefore, we ran the segmentation process for
all samples and obtained segmentation scores for samples in all
populations [SSP(P): the segmentation scores for pooled popu-
lations]. When we pooled samples and ran the pipeline, if the
gene being analyzed was not segmented into a single region for a
particular sample, then that sample was assigned a segmentation
score of zero. For example, the medianCCL3L1CN for European-
ancestry sample sets was less than other populations, therefore the
majority of segmentation results and z-scores (where needed—
see above) were less than zero. If the CCL3L1 gene region of a
European-ancestry sample was segmented into two sub-regions,
both having negative signs in the all-population analysis, then
this could either be recapitulated in the single-population analy-
sis (implying they were within the same CN region) or they could
be sub-regions that could span the population average. Thus,
they could have one negative and one positive sign (implying
they were within two distinct CN regions). In this case, however,
the pipeline only recognized that sub-regions shared the same
sign, and the two regions would therefore be considered as one
region and would be merged. To improve this, for each of the five
major populations, we fitted a linear regression line with SSP and
SSP(P) as independent and dependent variables respectively (data
for CCL3L1 are shown in Figure 2). This step aimed to reduce
errors when performing segmentation within single major popu-
lations or pooled populations. The fitted mean values of the five
single linear regression models were used as the final per sam-
ple segmentation scores for these five populations. Segmentation
scores were transformed and standardized, and a normal mix-
ture model was used to cluster the scores into CN genotype
groups.
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FIGURE 1 | A schematic diagram of the pipeline. CNVrd2 is a
modified version of CNVrd. CNVrd2 is identical to CNVrd at the
counting, transforming, standardizing and segmenting steps (A,B,G:
black text). However, CNVrd2 has additional steps: identification of
polymorphic regions (C), merging sub-regions inside genes/regions being
measured and testing boundary regions (D), using a simple linear
regression model to adjust segmentation scores between populations
(E) and a Bayesian normal mixture to cluster segmentation scores of
highly CN variable regions into different groups (F). These new steps
are in blue text.
PIPELINE WORKFLOW: ASSIGNING COPY-NUMBER COUNTS
A normal mixture model was used to cluster final segmentation
scores into different groups. If clear clusters were observed then
the Expectation Maximization (EM) algorithm (Dempster et al.,
1977) was used in the clustering process. If data were compli-
cated (e.g., loci with high copy-number variants such as CCL3L1
and DEFB103A) then a Bayesian clustering approach was used
(Step F, Figure 1; details of the analysis process for CCL3L1 and
DEFB103A are described below).
IDENTIFICATION OF WINDOW SIZE PARAMETERS FOR CNVrd2 USING
TEST LOCI
One of the new innovations in CNVrd2 was the merging of seg-
mentation results inside regions being measured if these regions
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FIGURE 2 | Linear relationship between the segmentation scores called for single populations and for all populations at CCL3L1. SSP, the
segmentation scores of a single large population; SSP(P), the segmentation score of pooled populations.
were divided into different parts (Step D, Figure 1). We merged
these parts if their signal values were above (below) a thresh-
old (namely “testThreshold2Merge” in the CNVrd2 package) for
duplicated events (deleted events). Another parameter was the
length of a boundary region, the default for which was set to
“half window size.” Real data sets were used for investigation of
the parameters of CNVrd2. In order to make reliable data sets we
intersected the CNV results of two sets of data (Conrad et al.,
2010; Campbell et al., 2011). From these intersecting data we
chose eight loci whose copy-number assignments were ≥45%
identical and whose lengths were in different ranges (∼3, ∼5, ∼8,
∼20,∼24,∼45,∼60,∼100 kb). The coordinates and CN status of
the 8 loci are described in Table 3. We only retained samples hav-
ing identical results between the methods. We downloaded BAM
files of the 1Mb regions around these loci and let CNVrd2 auto-
matically assign CN for the loci (CN groups of these loci were
known in advance from the micro-array based results, Table 3).
COMPARISONWITH CNVrd
We compared the new pipeline with our previous pipeline at the
eight loci mentioned above (Table 3) and the eleven loci previ-
ously measured in Nguyen et al. (2013). For the eight loci, both
pipelines were run and the percent concordances were calculated.
For CNVrd2, we used different window sizes (0.1, 0.2, 0.5, 1, 2,
5, 10, 20, and 50 kb) and different values (0.15, 0.25, 0.35, and
0.45) of testThreshold2Merge. For CNVrd, we only used differ-
ent windows (0.1, 0.2, 0.5, 1, 2, 5, 10, 20, and 50 kb) because the
merging process was not implemented in CNVrd. For the eleven
loci, we used a “testThreshold2Merge” value of 0.35 and the
same window size as CNVrd [FCGR3A and FCBR3B (1000 bp),
RHD (2000 bp), UGT2B17 (500 bp), GSTT1 (1000 bp), IGLL3P
(1000 bp), SMN2 (1000 bp), GSTM1 (200 bp), CFHR1 (500 bp),
CNTNAP3 (2000 bp) and IGLL5 (1000 bp)].
APPLICATION OF CNVrd2 TO TWO COMPLEX LOCI: CCL3L1 AND
DEFB103A
Windows of 500 and 1000 bp were used to analyze CCL3L1
and DEFB103A, respectively. Steps described above were used
to obtain putative boundaries of CCL3L1/DEFB103A gene-
containing regions and final segmentation scores for the two
loci. For each locus, one population having clear clusters of
segmentation scores was used to obtain prior information for
all populations: the European and South Asian population for
CCL3L1 and DEFB103A, respectively. This approach was imple-
mented using the EM algorithm (Dempster et al., 1977). The
results for the European and South Asian populations (means
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Table 3 | Eight loci which were obtained from the intersection of results of Conrad et al. (2010) and Campbell et al. (2011) were used to obtain
parameters for CNVrd2 and to compare between CNVrd2 and CNVrd.
Locus Region downloaded Sample sizea CNb
chr7:141769627-141793931 7:141000000-142000000 258 0 (3; 1.2) 1 (44; 17.1) 2 (208; 80.6) 3 (3; 1.2)
chr3:162514938-162619146 3:162000000-163000000 136 0 (93; 68.4) 1 (28; 20.6) 2 (15; 11.0)
chr17:44212815-44270230 17:43500000-44500000 252 2 (195; 77.4) 3 (38; 15.1) 4 (19; 7.5)
chr1:110222301-110242933 1:109500000-110500000 251 2 (106; 42.2) 3 (102; 40.6) 4 (43; 17.1)
chr17:44212815-44270230 17:43500000-44500000 252 2 (195; 77.4) 3 (38; 15.1) 4 (19; 7.5)
chr2:79331533-79339762 2:79000000-80000000 231 2 (218; 94.4) 3 (13; 5.6)
chr16:72109587-72112297 16:71500000-72500000 251 2 (226; 90.0) 3 (25; 10.0)
chr3:26434104-26439360 3:26000000-27000000 259 0 (3; 1.2) 1 (14; 5.4) 2 (240; 92.7) 3 (2; 0.8)
aThese samples result from the intersection of the samples of Conrad et al. and Campbell et al. (Conrad et al., 2010; Campbell et al., 2011) and the 1000 Genomes
Project.
bIn parentheses are the number and percentage of samples with the specified CN, as obtained from Conrad et al. (2010) and Campbell et al. (2011).
and variances of groups and the distances between the means
of the groups) were used to provide prior information for a
Bayesian normal mixture model that was applied to the other
populations. This was done to improve model stability and fit
for populations exhibiting high levels of CN polymorphism. The
Markov chain Monte Carlo sampling method implemented in
the rjags package (Plummer, 2011) was used to obtain poste-
rior estimates for each normal mixture model parameter—this
allows control of parameters using prior information. An adaptive
phase of 100 iterations was run, followed by a burn-in period
of 1000 iterations. Next, we ran 20,000 iterations and calculated
the means, standard deviations, and proportions of the mix-
ture components from 20% of the iterations. Convergence was
assessed by using Heidelberger and Welch’s stationarity and half-
width test implemented in the coda package (Plummer et al.,
2006).
COMPARISONWITH OTHER METHODS: CCL3L1
Copy number assignments at CCL3L1 by cn.Mops (Klambauer
et al., 2012), CNVnator (Abyzov et al., 2011) and Sudmant et al.
(2010) were compared to assignments of CNVrd2 on the 180
samples measured by the modified PRT. To run CNVnator, we
downloaded all of the chromosome 17 data for the 180 samples.
CNVnator was applied as previously described (Nguyen et al.,
2013). cn.Mops uses read-count information of single samples
and multiple samples to detect CN variable regions and uses
a Poisson mixture model to automatically infer CN. We used
CNVrd2 to obtain matrices of read counts in the 2Mb region
(chr17:33670000-34670000) in eight different scenarios: constant
windows of 25000, 20000, 10000, 5000, 2000, 1000, 500, and
200 bp with default values for other parameters. The 5000 bp win-
dow for cn.Mops had the highest proportion of samples having
CN > 3 and the highest concordance with other methods and
was used in the Figure 3 comparison. The Sudmant et al. (2010)
read count-based method utilized all possible mapping locations
of a read combined with singly unique nucleotide positions to
measure CN for 169 samples from the 1000 Genomes Project
at different loci, including the CCL3L1 gene. The CCL3L1 gene
results were validated by using Q-PCR based assays with high cor-
relation being observed (r = 0.95) (Sudmant et al., 2010). 111 of
the 169 samples overlapped with the samples analyzed here using
CNVrd2, and by Carpenter et al. (2011) using the PRT-based
methods. The coordinates ofCCL3L1 in the Sudmant et al. (2010)
data were chr17:34623842-34625730 (hg19).
COMPARISONWITH OTHER METHODS: DEFB103A
The data sets of Sudmant et al. (2010) and Hardwick et al. (2011)
were intersected and 104 samples were obtained that overlapped
with the 2535 1000 Genomes samples we analyzed using CNVrd2.
The coordinates of the DEFB103A gene in the Sudmant et al.
(2010) data were chr8:7738913-7740180 (hg19). For CNVnator,
we downloaded all of the chromosome 8 data for the 104 sam-
ples and used a similar approach as for CCL3L1. For cn.Mops,
we used CNVrd2 to obtain matrices of read counts in the 2Mb
region (chr8:6500000-8500000) for 2535 samples in eight differ-
ent scenarios: constant windows of 25000, 20000, 10000, 5000,
2000, 1000, 500, and 200 bp with default values for other parame-
ters. The 10000 bp window was the only window length to call CN
(six samples assigned CN = 3, the remainder assigned CN = 2)
and was used in the Figure 3 comparison.
LiftOver (Meyer et al., 2013) on the UCSC Genome browser
was used to convert coordinates of microarray data and the
Sudmant et al. (2010) data from Human Reference Genome hg18
to Human Reference Genome hg19.
RESULTS
DATA
Alignment results are presented in Figure 4. At CCL3L1 a total
of 395,078,047 reads across all samples were aligned to a 2Mb
region around the gene (Chr17:33670000-35670000). These reads
had lengths ranging from 36 to 160 bp (median of 91.5 bp and
the highest frequency, 44.9%, was 100 bp), and mapping qual-
ities from 0 to 70 (median of 33.5 and the highest frequency,
73.4%, was 60). The majority of reads (73.5% and 72.5%) align-
ing to the CCL3L1-containing region (chr17:34617501-3465201)
and CCL3L1 gene (Chr17:34623842-34625730) had a mapping
quality of 0, presumably reflecting multiple alignments to the
paralogs within the locus.
A total of 386,195,488 reads across all samples were aligned
to the 2Mb region on Chr 8 (Chr8:6500000-8500000) around
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FIGURE 3 | Comparison of copy number assignments of high-throughput sequencing-based with PRT-based methods. (A) CCL3L1 on 180 samples
[only 111 samples measured by Sudmant et al. (2010) overlapped]. (B) DEFB103A on 104 samples.
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FIGURE 4 | Read lengths and mapping qualities (top), mapping qualities (middle) and average read depth (bottom). Data for the 2MB CCL3L1 region
are on the left and the 2Mb DEFB103A region on the right.
the defensin genes (Figure 4). These reads had lengths ranging
from 36 to 160 bp (median of 91.5 bp and the highest frequency,
45%, was 100 bp), and mapping qualities from 0 to 70
(median of 33.5 and the highest frequency, 40.2%, was 60).
The majority of reads (64.1 and 99%, respectively) aligning
to the DEFB103A-containing gene (chr8:7641001-7742001) and
DEFB103A region (Chr8:7738726-7740105) had a mapping qual-
ity of 0. The average coverage of 2535 samples on the 2Mb
region was between 2.8 and 30.9× with a median of 6.9×
(Figure 4).
CNVrd2: INFERRING RELIABLE VALUES FOR PARAMETERS
We used eight loci derived from the data sets of two microarray
approaches (Conrad et al., 2010; Campbell et al., 2011) to obtain
parameters of CNVrd2. CNVrd2 had good performance when the
window size was 200 or 500 bp and a testThreshold2Merge value
of 0.35 was used (Figure 5). A small window size (e.g., 100 bp)
was not stable at all loci, possibly because there were multiple
low-coverage samples in the 1000 Genomes Project data (e.g.,
464/2535 = 18.2% samples having coverage in the CCL3L1 gene-
containing 2Mb region< 5×, Figure 4). This could lead to some
windows having very low read counts, and thus being segmented
incorrectly. For example, some windows in normal regions (i.e.,
CN = 2) would be segmented into deleted regions or some win-
dows in duplicated regions would be segmented into normal
regions. Similarly, large windows (e.g., 5000 bp) also generated
unreliable results (Figure 5).
CNVrd2: COMPARISONWITH CNVrd AT EIGHT TEST LOCI
Our previous work was focused on loci having low copy-number
ranges. Even though this present study is concentrated on loci
with CN range from zero to >5 CN, we also compared with
CNVrd (Nguyen et al., 2013) to assess the performance of the
modified pipeline, especially in the steps requiring obtaining
and adjusting segmentation scores for each sample. Loci used
in this comparison had copy number ranging from 0 to 5, and
their boundaries were known (Table 3 and Nguyen et al., 2013).
Therefore, a simple normal mixture model was used in CNVrd2
to cluster segmentation scores into different groups. CNVrd2 had
more stable results than those of CNVrd at almost all window
sizes (Figures 5, 6). Merging sub-regions and adjusting bound-
aries (Step D and E, Figure 1) produced more reliable results
for CNVrd2 at two complex regions (chr17:34436344-34481815
and chr1:110222301-110242933). At these two regions, CNVrd
showed very low concordance with microarray-based approaches
(Figure 6).
CNVrd2: COMPARISONWITH THE ELEVEN LOCI USED IN CNVrd
We also applied CNVrd2 to eleven CNV regions (including
FCGR3A/3B) to which CN was assigned using CNVrd in our
previous work (Nguyen et al., 2013). Better concordances were
seen at five loci for CNVrd2 (CFHR1: 94.29/91.9%, RHD:
99.05/98.57%, GSTM1: 95.24/93.81%, SMN2: 90.95/88.1%,
UGT2B17: 99.05/97.14%) and the same concordances were
seen at the other four loci (GSTT1: 94.76%, IGLL5: 95.24%,
CNTNAP3: 81.43%, IGLL3P: 99.52%). For FCGR3A and
FCGR3B, applying CNVrd2 to the same set of 952 samples in our
previous work produced slightly higher concordances than for
CNVrd when compared with PRT-basedCN assignments (Hollox
et al., 2009) (FCGR3A: 84.2/82% and FCGR3B:83.5/82.7% for
CNVrd2 and CNVrd, respectively).
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FIGURE 5 | Concordance between the CNVrd2 and microarray based results. The x-axis contains the values of testThreshold2Merge (0.15, 0.25, 0.35,
0.45). The y-axis is the percentage of identical results.
APPLICATION OF CNVrd2 TO TWO COMPLEX LOCI; CCL3L1 AND
DEFB103A
Information on read length, mapping quality, read depth and read
count ratios is presented in Subjects and Methods (“HTS and
microarray data used”) and in Figure 4.
Based on the results of the eight test loci (above, Figures 5, 6),
the BAM files were processed using 500 bp windows for CCL3L1
and 1000 bp windows for DEFB103A, and a testThreshold2Merge
= 0.35. 1000 bp windows were chosen for DEFB103A because
there was higher correlation between segmentation scores of
DEFB103A and DEFB103B than for 500 bp windows (r = 0.80
and 0.78, respectively). Owing to the small length of each gene
(1888 bp for CCL3L1 and 1379 bp for DEFB103A) larger window
sizes were not investigated as this could result in not detecting
breakpoints nearby or inside the genes.
POLYMORPHISM OF THE CCL3L1 LOCUS
Using a 2Mb region it took approximately 3 h to assign copy
number at CCL3L1 on 2535 samples using a 4-core com-
puter with 8Gb memory. Standard deviations and different
percentiles of the segmentation results of sub-regions on the
2-Mb region were calculated to visually detect this region. Using
a standard deviation threshold of 0.5, we identified CCL3L1
within a large polymorphic CN variable region of approximately
329 kb (chr17:34436001-34815000, which included a 50 kb gap)
(Figure 7). This region included small CNV blocks of clearly
defined increased standard deviation (SD) which suggested that
there would be multiple recombination events inside the CNV
region. CCL3 was outside this region, CCL4 was at the boundary,
while CCL3L1 was in a second block with CCL3L3 and CCL4L1.
The CCL3L1 gene was located in a sub-region which had SDs
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FIGURE 6 | Concordance between the CNVrd and microarray based results. Window sizes are shown on the x-axis, while the y-axis shows the percentage
of identical results.
fluctuating around 0.84 and 0.85. CCL3L3 and CCL4L1 were
also in a sub-region with SDs fluctuating around 0.83 and 0.86,
but these sub-regions were separated from the CCL3L1 gene-
containing sub-regions by a decrease (0.8) in SDs between two
blocks (Figure 7). We merged these sub-regions and the bound-
aries of the CCL3L1-containing region were chr17:34617501-
34652500. Using CNVrd2, we obtained segmentation scores for
both the CCL3L1 gene-containing region and the larger CCL3L1
region. The segmentation scores of the two regions were strongly
correlated (r = 0.98, Figure 8).
ASSIGNING CCL3L1 COPY NUMBER
The European CCL3L1 segmentation results from the smaller
35kb gene-containing region were assigned by CNVrd2 to five
groups (Figure 9). All clusters were clearly delineated, although
the highest group exhibited some scatter. The results obtained
from the EM algorithm applied to the European samples were
used as prior information to obtain CCL3L1 CN estimates for
the 2535 samples from the 1000 Genomes Project. The final
segmentation scores across all samples ranged from −1.66 to
4.53 (Figure 9), with only one score being larger than 3.42.
This value was considered to be an outlier, and the associ-
ated sample (HG00620 in the CHS population) was assigned to
the largest copy number group with a probability of 1. Thus,
the segmentation score range used to determine the number of
groups was between −1.66 and 3.42. The distances between the
groups in the European population ranged between 0.39 and 0.62.
As a result, 10 groups were chosen to encompass the range of
CN values for the full collection of samples. The Markov Chain
Monte Carlo chain was convergent after 10,000 iterations and the
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FIGURE 7 | Plots of polymorphic regions encompassing CCL3L1 (A)
and DEFB103A (B). The plots show standard deviation (top) and different
percentiles (bottom) across 2Mb sub-regions (for all 2535 samples).
segmentation scores were clustered into 10 groups corresponding
to CN from 0 to ≥9 (Figure 9).
The CN assignments for European-ancestry populations
ranged between 0 and 5, with the highest frequency (43.6%,
220/505) being 2 copies (Table 1). Similar to the European-
ancestry populations, CN = 2 was the most common (42.1%;
208/494 samples) in the South Asian sample set. The East Asian
sample set had CN between 0 and ≥9, with the most common
being CN = 3 (36.7%, 189/515). CN = 3 was also the most fre-
quent in the Americas sample set, with the highest CN = 8. The
African sample sets had no individuals having 0 copies and just
FIGURE 8 | Correlation between segmentation scores of
CCL3L1/DEFB103A and polymorphic regions encompassing the genes.
10 samples (1.5%) having 1 copy, with 3–5 copies being the most
common (Table 1).
VALIDATION OF CCL3L1 CN ASSIGNMENTS WITH PARALOG RATIO
TEST (PRT) DATA
The CNVrd2 results on 180 of the samples were compared to
data where CCL3L1 CN had previously been determined using
PRT—45 European samples measured by Carpenter et al. (2011)
and 135 African and Asian samples measured by Janyakhantikul
et al. (2010). There was 77.8% (140/180) identity between the two
methods (Figure 3A). The majority of discordant results were for
high CN samples and differences were of one CN.
COMPARISON OF CNVrd2 WITH OTHER READ DEPTH-BASED
METHODS AT CCL3L1
The packages CNVnator (Abyzov et al., 2011) and cn.Mops
(Klambauer et al., 2012) were compared to CNVrd2 (refer also to
Subjects and Methods). In addition, we also used the 159 genome
data set of Sudmant et al. (2010). Copy number for samples in
this data set were measured using a read depth-based method, but
the authors used the mrsFAST aligner (Hach et al., 2010) which
obtains all possible positions of a read. The concordance rates for
CNVnator, cn.Mops, and the approach of Sudmant et al. (2010)
with CCL3L1 PRT-based results were 7.2% (13/180, r = 0.95),
36.7% (66/180, r = 0.65), and 0% (0/111, r = 0.93) respectively
(Figure 3). The highest CNs called by CNVnator and cn.Mops
were only 5 and 4 respectively. CN assignments of Sudmant et al.
(2010) were significantly higher than the modified PRT results,
although assignments of the two methods were highly correlated
(r = 0.93) (Figure 3).
To investigate the discordant results of the other packages
with the PRT-based method at CCL3L1, observed read-count
ratios of European sample sets and all 2535 samples were calcu-
lated for both the CCL3L1 gene region and CCL3L1-containing
region (Figure 10). The two medians of these ratios were consid-
erably less than 1 (0.7 and 0.8, respectively), while the expected
median was 1. For the larger CCL3L1-containing region, 74.7%
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FIGURE 9 | Segmentation scores and CN groups at the CCL3L1 and DEFB103A loci. Segmentation scores of all populations (bottom). Small populations
(European for CCL3L1 and South Asian for DEFB103A) are in red. The top pictures show segmentation scores and their CN groups.
FIGURE 10 | Observed read-count ratios of samples at the CCL3L1/DEFB103A gene (medians: 0.7 and 1 respectively) and the
CCL3L1/DEFB103A-containing region (medians: 0.8 and 1 respectively).
(1893/2535) of samples had ratio <1, 76.4% (1938/2535) for
the 35kb CCL3L1 region. Reads of samples having zero copies
which were aligned to CCL3L1 gene region were very close to
zero (Table 4), and thus the density of reads at CCL3L1 was not as
high as expected. Approaches based solely on read depth with no
cross-sample standardization would therefore have difficulty in
accurately assigning CCL3L1CN, especially for high-CN samples,
which would be assigned to lower-CN groups.
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Table 4 | Read counts at the CCL3L1 gene (chr17:34623842-34625730)
(1.9 kb) of samples called 0 copies by CNVrd2.
Sample Average Read count Read count Population
ID coverage at CCL3L1 at CCL3L1-
(2Mb) containing region
HG00240 7.3 1 75 GBR
HG00290 7.4 0 36 FIN
HG00336 3.4 0 35 FIN
HG00410 10.1 0 69 CHS
HG00553 3.3 0 29 PUR
HG01112 4.8 0 37 CLM
HG01204 4.8 0 109 PUR
HG01260 7.2 1 40 CLM
HG01280 8.1 0 23 CLM
HG01286 4.6 4 68 PUR
HG01302 5.4 0 23 PUR
HG01474 5.1 0 40 CLM
HG01489 5.2 0 58 CLM
HG01504 5.3 0 42 IBS
HG01506 6.4 0 30 IBS
HG01550 4.7 0 38 CLM
HG01767 8.3 0 42 IBS
HG01864 8.4 0 64 KHV
HG01873 20.2 0 103 KHV
HG02122 6.2 0 58 KHV
HG02385 4.6 0 19 CDX
HG02604 7.1 2 78 PJL
HG02648 6.9 0 37 PJL
HG02652 6.9 0 45 PJL
HG02658 8.8 3 127 PJL
HG03589 5.8 0 48 BEB
HG03673 8.6 2 68 STU
HG03968 5.4 2 34 ITU
HG04019 5.6 0 39 ITU
HG04062 4.0 0 21 ITU
HG04156 5.4 0 32 BEB
NA07056 5.8 0 54 CEU
NA11831 5.8 1 67 CEU
NA18574 4.7 0 66 CHB
NA20507 6.1 0 49 TSI
NA20540 3.9 0 67 TSI
NA20589 7.0 0 41 TSI
NA20754 8.2 0 33 TSI
NA20762 7.0 0 42 TSI
NA20764 8.3 1 44 TSI
NA20778 8.3 0 78 TSI
NA20850 4.1 0 30 GIH
NA20903 7.7 0 43 GIH
The average coverage is calculated for the 2Mb region (chr17:33670000-
35670000).
POLYMORPHISM OF THE DEFB103A LOCUS
The DEFB103A region lies within a polymorphic inversion with
complex structure (Sugawara et al., 2003). We used quantile
values and standard deviations across sub-regions to visually
identify the boundaries of the polymorphism encompassing the
gene. Using a standard deviation threshold of 0.5, DEFB103A
was identified within a large CN polymorphic region (consis-
tent with Groth et al., 2008) of 1078 kb (chr8:70200000-7474000
7532001-8098000 including a 58 kb gap) (Figure 7). This CNV
region also included small polymorphic blocks which suggested
that there would be multiple recombination events inside the
CNV region. DEFB103A was in the same block as DEFB104A
and DEFB107A. The standard deviations of this block fluctu-
ated around 0.70 and 0.74. We merged these sub-regions and
the boundaries of the DEFB103A gene-containing region were
chr8:7641001-7742000. The segmentation scores of this region
and the larger DEFB103A gene region were strongly correlated
(r = 0.95, Figure 8). We used this region to calculate CN for
DEFB103A. The DEFB4A gene was outside this block owing to
a relatively high peak (SD was 0.81 whilst the maximum SD of
the DEFB103A gene-containing region was only 0.74) between
DEFB4A and the DEFB103A block (Figure 7).
We also calculated segmentation scores of DEFB103B (para-
log of DEFB103A) to compare segmentation scores of this gene
and those of the DEFB103A gene-containing region. The seg-
mentation scores of the two regions were not as highly corre-
lated (r = 0.83), but they made clear clusters of distinct groups
(Figure 11).
ASSIGNMENT OF DEFB103A CN
The segmentation scores of the gene had clear clusters (Figure 9)
with some scattered values >3, therefore these values were allo-
cated into the largest (>3) group. The South Asian popula-
tion had the clearest clusters therefore we used this population
to obtain prior information and ran the EM algorithm upon
the segmentation score with six groups. The distances between
the groups were 0.50–0.69 therefore 0.57 was set as the prior
distance. Eight groups were defined for all segmentation scores
and CNVrd2 was used to assign DEFB103A copy-number using
similar parameters as for CCL3L1 in the Bayesian clustering
process (Table 2). Because the observed read count ratio range
was reasonable (0.53–1.93) (Figure 11), this suggested that the
lowest CN was greater than zero, with the scattering of values
on the left (Figure 9) assigned to the smallest group (CN = 2)
during the clustering process. A CN of 4 was the most common
in all populations (Table 2; 26.3–47.9%), consistent with previous
reports (Armour et al., 2007; Hardwick et al., 2011).
CNVrd2 obtained high concordance with PRT-based meth-
ods (90.4%, r = 0.95, 94/104) (Figure 3). PRT CN assignments
for 104 samples were available (Hardwick et al., 2011) that also
overlapped with the samples analyzed by Sudmant et al. (2010).
The concordances between Sudmant et al. (2010), CNVnator
(Abyzov et al., 2011) and cn.mops (Klambauer et al., 2012)
(using 10 kb windows for cn.mops) with PRT-based methods
were 54.8% (57/104), 1% (1/104) and 4.8% (5/104) respectively.
The majority of differences between CNVrd2, Sudmant et al.
(2010) and the PRT-based methods were one copy.
DISCUSSION
The CNVrd2 package, depicted in Figure 1, is an improved ver-
sion of CNVrd previously used to assign CN at the FCGR locus
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FIGURE 11 | Correlation between segmentation scores of the
DEFB103A gene-containing region and the enlarged region
encompassing DEFB4A (top left) and the DEFB103B gene
region (bottom left). On the right are histograms of
segmentation scores of the enlarged region (top) and DEFB103B
region (bottom).
(Nguyen et al., 2013). CNVrd2 was designed to correct issues that
can occur during the segmentation process which can result in
CNVrd assigning a segmentation score of zero, resulting in some
samples being assigned to unreasonable CN groups. In addi-
tion, in CNVrd2, a linear regression model was used to adjust
the differentiation in CN between populations. Clustering data
into different groups is challenging at complex loci with high
ranges of CN. Therefore, a Bayesian clustering strategy was inte-
grated into CNVrd2 in order to obtain more reliable results at
CCL3L1 andDEFB103A. Finally, plots of percentiles and standard
deviations of segmentation results were also added to CNVrd2.
These can be used as visual tools to identify copy-number variable
regions encompassing loci being measured (Figure 7). In evalu-
ating our results, it should be noted that CNVrd2 was developed
on the FCGR and CCL3L1 loci. Therefore, the concordance com-
parisons are biased toward CNVrd2. However DEFB103A can be
regarded as a genuine test locus, on which CNVrd2 performed
well (Figure 3). There is a paucity of loci for which published PRT
gold-standard data are available on complex CN loci.
CNVrd2 obtains higher concordance with PRT-based methods
than other CN-assigning approaches. However the concordance
was not 100% (Figure 3; 77.8% at CCL3L1 and 90.4% at
DEFB103A), which would limit its use in case-control analysis of
complex CN loci in common disease. We used BWA alignments
from the 1000 Genomes Project, where the majority of mapping
qualities were zero owing to reads having multiple hits within
segmental duplications. Further improvement of CNVrd2 could
come from the use of alignments better optimized to detect CNV,
such as mrsFAST (Hach et al., 2010) which allows diverged par-
alogs (1–2% difference) to be differentiated. It is important also
to stress that CNVrd2 was developed to measure CN at speci-
fied loci, while other comparison packages are more automated
approaches that both detect CNV and assign CN. CNVrd2 is auto-
mated to produce individual segmentation scores at a locus and
assign CN using the Bayesian Information Criterion (Schwarz,
1978). However it is better to manually undertake the clustering
process as we did in this study. The reason is that clear clusters
were not seen at complex loci CCL3L1 and DEFB103A. Note that
CNVrd2 is enhanced by some prior knowledge of CN.
From the observed read count ratio analysis (Figure 10), it can
be seen that if only the read-count information from one sam-
ple is used to assign CN (as is done by CNVnator) the majority
of samples at the CCL3L1 locus would likely be called as deletions
because of the inherently low number of reads in that region, pos-
sibly resulting from CCL3L1 reads mapping to paralogs nearby.
The majority of populations had observed read-count ratios of
less than 1. This could also be the reason that the cn.Mops package
did not call high CN for multiple samples (Figure 3). Complete
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discordance was seen between the Sudmant et al. (2010) CCL3L1
results obtained using multiple hits of a read and all other meth-
ods (Figure 3). The results of Sudmant et al. (2010) had been
validated by PCR-based methods with good correlation. It is
important to note that PCR-basedmethods are unreliable inmea-
suring complex gene CN (Walker et al., 2009; McKinney and
Merriman, 2012)—any differences in amplification efficiency that
alters the ratio between the test and reference genes will alter
the apparent CN (Armour et al., 2007). One possible reason
for the Sudmant et al. (2010) discordance could be the use of
different clustering strategies, but it could also be due to using
different alignment methods when there are >1 read-mapping
possibilities: choosing a random position (CNVrd2) vs. using all
possible positions for a read (Sudmant et al., 2010). We checked
the only sample (NA11831) called CN = 1 by Sudmant et al.
(2010) and zero by CNVrd2, cn.Mops, CNVnator, and PRT-based
methods. There was only one read aligned to CCL3L1 (Table 4),
while the average coverage for this sample on the 2Mb region
was adequate (5.8×). Similarly, checking all samples called as
0 copies by CNVrd2, we also saw that the number of reads
aligned to the CCL3L1 gene region were extremely low (Table 4).
This suggests that the sample NA11831 was correctly assigned
CN = 0 for CCL3L1 by the PRT methods and the BWA aligner
based next-generation sequencing methods (CNVrd2, CNVnator,
cn.Mops).
At the beta-defensin locus, we identified a CNV region which
had nearly equal standard deviations of sub-regions. This CNV
region encompassed DEFB103A. The segmentation scores of this
and the DEFB103B region (Figure 7; on the polymorphic section
before the gap) were moderately correlated (r = 0.83) but they
made clear clusters of different groups (Figure 11). This suggested
that individual CNs of the two regions would be nearly identical.
However, the identified region did not include the DEFB4A gene
because we saw a high peak between the region and DEFB4A gene
(Figure 7). We retested with different windows (500 and 2000 bp)
and still observed this peak (data not shown). An enlarged region
that included the peak and DEFB4A was strongly correlated with
the smaller region (r = 0.95) but had multiple samples with a
score of zero, because in CNVrd2 if a region was segmented into
different sub-regions having different signs then the segmentation
score of the region was assigned to zero. This suggested that there
was not full duplication of the enlarged region (Figure 11). This
situation could occur because of an error in the alignment pro-
cess, or because there were heterogenous breakpoints within the
enlarged region.
At the complex CCL3L1 and DEFB103A loci CNVrd2 assigned
CN with greater accuracy than the other read depth-based CN
assignment methods CNVnator and cn.Mops. The CNVrd2
package is implemented in R (as of version 3.0.1) and is avail-
able from Bioconductor (as of version 2.14) at http://www.
bioconductor.org/packages/release/bioc/html/CNVrd2.html,
where installation and usage instructions can be found.
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